(Q39327842)

11 September 2017

title

Measles virus selectively blind to signaling lymphocyte activation molecule as a novel oncolytic virus for breast cancer treatment (English)

1 reference

11 September 2017

0 references

1 reference

1 reference

T Sugiyama

1

1 reference

11 September 2017

M Yoneda

2

1 reference

11 September 2017

T Kuraishi

3

1 reference

11 September 2017

S Hattori

4

1 reference

11 September 2017

Y Inoue

5

1 reference

11 September 2017

H Sato

6

1 reference

11 September 2017

C Kai

7

1 reference

11 September 2017

publication date

21 June 2012

1 reference

11 September 2017

1 reference

11 September 2017

volume

20

1 reference

11 September 2017

issue

3

1 reference

11 September 2017

page(s)

338-347

1 reference

11 September 2017

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

Treatment of metastatic breast cancer: second line and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

The emerging role of viruses in the treatment of solid tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

Engineered measles virus as a novel oncolytic therapy against prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

A measles virus vaccine strain derivative as a novel oncolytic agent against breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

A novel receptor involved in T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

SLAM (CDw150) is a cellular receptor for measles virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

The human CD46 molecule is a receptor for measles virus (Edmonston strain)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

Nectin4/PRR4, a new afadin-associated member of the nectin family that trans-interacts with nectin1/PRR1 through V domain interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

Identification of nectin-4 oncoprotein as a diagnostic and therapeutic target for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

Nectin 4 overexpression in ovarian cancer tissues and serum: potential role as a serum biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

Nectin-4 is a new histological and serological tumor associated marker for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

Selectively receptor-blind measles viruses: Identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

Heparin-like glycosaminoglycans prevent the infection of measles virus in SLAM-negative cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

Immune responses against measles virus in cynomolgus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

Recovery of pathogenic measles virus from cloned cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

Infection of cynomolgus macaques (Macaca fascicularis) and rhesus macaques (Macaca mulatta) with different wild-type measles viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

Experimental measles. II. Infection and immunity in the rhesus macaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

Predominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

Measles virus selectively blind to signaling lymphocytic activation molecule (SLAM; CD150) is attenuated and induces strong adaptive immune responses in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

Complement resistance of tumor cells: basal and induced mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

Evasion of host defenses by measles virus: wild-type measles virus infection interferes with induction of Alpha/Beta interferon production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

Dissection of measles virus V protein in relation to its ability to block alpha/beta interferon signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

Measles viruses possessing the polymerase protein genes of the Edmonston vaccine strain exhibit attenuated gene expression and growth in cultured cells and SLAM knock-in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

Cell carriers for oncolytic viruses: Fed Ex for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

Systemic therapy of disseminated myeloma in passively immunized mice using measles virus-infected cell carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

Measles virus infects both polarized epithelial and immune cells by using distinctive receptor-binding sites on its hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

CD147/EMMPRIN acts as a functional entry receptor for measles virus on epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

B95a, a marmoset lymphoblastoid cell line, as a sensitive host for rinderpest virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

Characterization of monoclonal antibodies directed against the canine distemper virus nucleocapsid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

Efficient selection for high-expression transfectants with a novel eukaryotic vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

Oncolytic measles virus strains in the treatment of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

7 January 2021

Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

7 January 2021

Adherens junction protein nectin-4 is the epithelial receptor for measles virus

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

7 January 2021

Integrated imaging approach to tumor model mice using bioluminescence imaging and magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

7 January 2021

The significance of Survivin and Nectin-4 expression in the prognosis of breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

7 January 2021

Comparison of subcutaneous and intraperitoneal injection of D-luciferin for in vivo bioluminescence imaging

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.44

7 January 2021

Identifiers

DOI

10.1038/GT.2012.44

1 reference

11 September 2017

1 reference